Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ALT compared with LBRX: revenue, margins and what each company keeps, and the suppliers and customers both name
ALT
Altimmune, Inc.
Change
Mkt cap
Revenue
Revenue
LBRX
LB Pharmaceuticals Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
ALT
Altimmune, Inc.
vs
LBRX
LB Pharmaceuticals Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
No disclosed counterparties: ALT, LBRX.
Role chip = supplier or customer
Source: SEC EDGAR
ALT
Altimmune, Inc.
Change
2.05
▲
+1.25%
· post 2.05
· delayed
Mkt cap
$396.8M
Revenue
$26,000
Q4 FY25
Revenue
$41,000
FY25
LBRX
LB Pharmaceuticals Inc
Change
40.44
▲
+3.58%
· post 40.45
· delayed
After hours
Nov 3 '26
delayed
Mkt cap
$1.2B
Revenue
—
Revenue
—
vs
Compare
After hours
Nov 3 '26
delayed
ALT
Altimmune, Inc.
vs
LBRX
LB Pharmaceuticals Inc
2.05
▲
+1.25%
post 2.05
delayed
Price
40.44
▲
+3.58%
post 40.45
delayed
$396.8M
Mkt cap
$1.2B
Q4 FY25
$26,000
Revenue
—
FY25
$41,000
Revenue
—
Change
Change
ALT
2.05
▲
+1.25%
vs
LBRX
40.44
▲
+3.58%
After hours
Nov 3 '26
delayed